RELCHEMQ — Reliance Chemotex Industries Income Statement
0.000.00%
- IN₹1.26bn
- IN₹3.63bn
- IN₹3.67bn
- 29
- 43
- 30
- 23
Annual income statement for Reliance Chemotex Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,998 | 2,556 | 3,618 | 3,649 | 3,672 |
Cost of Revenue | |||||
Gross Profit | 1,009 | 945 | 1,440 | 1,322 | 1,284 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,758 | 2,399 | 3,211 | 3,396 | 3,461 |
Operating Profit | 240 | 157 | 406 | 253 | 211 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 108 | 104 | 274 | 167 | 56.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 93.3 | 69.3 | 181 | 124 | 32.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 93.3 | 69.3 | 181 | 124 | 32.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 93.3 | 69.3 | 181 | 124 | 32.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 14.6 | 9.32 | 24.6 | 16.9 | 4.25 |
Dividends per Share | |||||
Special Dividends per Share |